Chimeric antigen receptor T cell and regulatory T cell therapy in non-oncology diseases: A narrative review of studies from 2017 to 2023

Recently, the remarkable success of chimeric antigen receptor T cell (CAR-T) therapy in treating certain tumors has led to numerous studies exploring its potential application to treat non-oncology diseases. This review discusses the progress and evolution of CAR-T cell therapies for treating non-on...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ming-Yao, Li, Wanyang, Chen, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Immunotherapy - Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566417/
https://www.ncbi.nlm.nih.gov/pubmed/37814513
http://dx.doi.org/10.1080/21645515.2023.2251839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566417/
https://www.ncbi.nlm.nih.gov/pubmed/37814513
http://dx.doi.org/10.1080/21645515.2023.2251839

Ejemplares similares